ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1263

The Prevalence and Patterns of Celiac Disease Associated Arthropathy and Coexistence of Celiac Disease with Rheumatic Disorders in a Single Tertiary Medical Center

Anita Moudgal1, Pooja Bhadbhade 1, Ammar Haikal 1 and Mehrdad Maz 1, 1The University of Kansas Medical Center, Kansas City, KS

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Arthritis, rheumatic disease and auto-immunity

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Miscellaneous Rheumatic & Inflammatory Disease Poster II: Autoinflammation Related Diseases & Therapies

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Celiac disease (CD) is a gluten-sensitive enteropathy that develops in genetically predisposed individuals. Arthropathy has been reported as an extra-intestinal manifestation of CD. The pathogenesis of arthropathy is unclear; however, the immunologically mediated mucosal injury may lead to absorption of immune complexes or gut-derived antigens which may provoke antibody mediated autoimmune diseases including rheumatic diseases and arthropathy. We report a retrospective chart review of 35 confirmed cases of CD associated arthropathy and coexisting rheumatic or inflammatory disorders.

Methods: Heron database was used to search for patients seen by Gastroenterology and/or Rheumatology between January 2008 to January 2018 with suspected CD based on ICD-9 code for CD. These charts were retrospectively reviewed to determine who had confirmed CD, joint pain and pattern of involvement, dietary compliance, and other inflammatory or rheumatic disorders.  The diagnosis of CD was based on serology specific for tissue transglutaminase (tTG) antibody, endoscopic and histological results, compliance with gluten free diet, and clinical judgement.

Results: A total of 95 patients with suspected CD were identified. 35/95 had confirmed CD. Of the 35 patients, 29 were female and 34 self-identified as Caucasian. The average age of patients was 49 years. Of the 35 patients, 22 patients did not have a co-existing rheumatic or inflammatory disorder. This cohort of 22 patients endorsed symptoms in the following distribution: 82% (18/22) had peripheral only, 0% (0/22) had axial only, and 18% (4/22) had peripheral and axial involvement. Of the 22 patients, 54% (14/22) endorsed arthropathy in small joints, 91% (20/22) in medium joints, and 82% (18/22) in large joints.  Improvement in arthralgia after transitioning to a gluten-free diet was reported in 4/22 patients. A total of 13/35 with confirmed CD diagnosis had a rheumatic and/or inflammatory disorder. Rheumatoid Arthritis had the highest prevalence at 11% (4/35) followed by IBD (3), UCTD (2), Sjorgen’s Syndrome (1), Scleroderma (1), Symmetric Inflammatory Polyarthritis (1), and Psoriasis (1). Fibromyalgia, a non-inflammatory condition, was reported in 6% (2/35) of patients. 3 patients were not seen by rheumatology.

Conclusion: CD associated arthropathy and coexistence of CD with rheumatic and/or inflammatory disorders are under-recognized. Our data demonstrates that 63% of patients had CD associated arthropathy who appear to be a unique subset separate from those with coexisting CD and rheumatic/inflammatory disorders.  Identifying the association and pattern of arthropathy in CD will aid in management of patients who either present to a gastroenterologist with extra-intestinal manifestations or to a rheumatologist with gastrointestinal manifestations. The awareness that CD can coexist in rheumatic diseases will aid rheumatologists in more effective recognition and management of patients with such presentations.


Celiac Abstract Image 1

Total Cohort with Suspected Celiac Disease


Celiac Abstract Image 2

Confirmed Cases of Celiac Disease


Disclosure: A. Moudgal, None; P. Bhadbhade, None; A. Haikal, None; M. Maz, None.

To cite this abstract in AMA style:

Moudgal A, Bhadbhade P, Haikal A, Maz M. The Prevalence and Patterns of Celiac Disease Associated Arthropathy and Coexistence of Celiac Disease with Rheumatic Disorders in a Single Tertiary Medical Center [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-prevalence-and-patterns-of-celiac-disease-associated-arthropathy-and-coexistence-of-celiac-disease-with-rheumatic-disorders-in-a-single-tertiary-medical-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prevalence-and-patterns-of-celiac-disease-associated-arthropathy-and-coexistence-of-celiac-disease-with-rheumatic-disorders-in-a-single-tertiary-medical-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology